FDA Clearance Tracker · K233512
Rapid (6.0)
Last checked: Nov 20, 2026Latest source record: Jan 16, 2024 (this decision)Source: openFDAMethods & limitations
Decided
Jan 16, 2024
Substantially Equivalent
Time to decision
76 days
Received Nov 1, 2023. Calendar days, including time FDA spent waiting on the applicant.
Pathway
510(k)
Special
Device class
Class II
The decision
- FDA number
- K233512
- Device name
- Rapid (6.0)
- Applicant
- Ischemaview, Inc.
- Applicant location
- Golden, CO
- Received
- Nov 1, 2023
- Decided
- Jan 16, 2024
- Decision
- Substantially Equivalent
- Submission type
- Special
Device type
- Device class
- Class II
- Regulation
- 21 CFR 892.2050
How new is this?
These are facts about FDA's records. They are not a judgment about the device.
- It is not the first decision under product code QIH. The earliest in FDA's data is K191171, decided Nov 13, 2019.
- It is not on FDA's public list of Breakthrough Devices with marketing authorization (list dated June 30, 2026). FDA does not publish which devices hold the designation before they are authorized, and the list is updated only a few times a year.
Source documents
- FDA database record for K233512
- 510(k) summary (PDF) · FDA posts these some weeks after the decision, so a recent one may not open yet.
The predicate devices this clearance relied on are named in the summary document. We do not extract them yet.
Other decisions for Ischemaview, Inc.
Matched on the applicant name as FDA recorded it. A company that files under several names will have more.
- Rapid ICH (v4.0)510(k)
K262301 · Decided Oct 9, 2026 · 94 days after receipt
Device type: Radiological Computer-Assisted Triage And Notification Software (QAS) · Radiology & Imaging
- Rapid Platform (R6.7)510(k)
K261368 · Decided Sep 21, 2026 · 147 days after receipt
Device type: Automated Radiological Image Processing Software (QIH) · Radiology & Imaging
K251987 · Decided Sep 23, 2025 · 88 days after receipt
Device type: Automated Radiological Image Processing Software (QIH) · Radiology & Imaging
5 more FDA decisions with a free account
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.